chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chills, Dyspnoea, Nausea, Paranasal sinus discomfort
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 66 y/o female w/ PMH of emphysema who presents to ED on 05/15/22 with 10 days of nausea in the setting of COVID19 infection. Admitted to hospital with nausea, fever, chills, sinus pressure, intermittent breathlessness and mild phlegm production. Supportive care and supplemental o2 prn given. Pt improved and discharged to home on 05/16. Other Relevant HX: 66 y/o female w/ PMH of emphysema, HLD, HTN, restless legs, hypothyroidism, and vitamin d deficiency. Other: COVID Infection with hospitalization
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Productive cough, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 66 y/o female w/ PMH of emphysema who presents to ED on 05/15/22 with 10 days of nausea in the setting of COVID19 infection. Admitted to hospital with nausea, fever, chills, sinus pressure, intermittent breathlessness and mild phlegm production. Supportive care and supplemental o2 prn given. Pt improved and discharged to home on 05/16. Other Relevant HX: 66 y/o female w/ PMH of emphysema, HLD, HTN, restless legs, hypothyroidism, and vitamin d deficiency. Other: COVID Infection with hospitalization
Sex: M
Vaccine: FLUX
Symptoms: Anaphylactic reaction
Clinical narrative: Reported Symptoms:  10002218:ANAPHYLAXIS; Narrative: patient treated and responded without long lasting effects. Administered influenza vaccine the following year without issues. Other Relevant HX: Other: ANAPHYLAXIS
Age: 56.0
Sex: M
Vaccine: VARZOS
Symptoms: Cardio-respiratory arrest, Feeling hot, Loss of consciousness, Respiratory arrest, Respiratory depression
Clinical narrative: Reported Symptoms: 10038678:RESPIRATORY DEPRESSION; Narrative: Patient experience feeling hot and mild tightness in his throat and vision was fuzzy after receiving shot. He was given an EPI pen. Patient coded in the clinic, stopped breathing and LOC for 10-15 seconds. Vomited afterward and was transmitted to the ER. Other Relevant HX: Other:
Age: 56.0
Sex: M
Vaccine: VARZOS
Symptoms: Throat tightness, Vision blurred, Vomiting
Clinical narrative: Reported Symptoms: 10038678:RESPIRATORY DEPRESSION; Narrative: Patient experience feeling hot and mild tightness in his throat and vision was fuzzy after receiving shot. He was given an EPI pen. Patient coded in the clinic, stopped breathing and LOC for 10-15 seconds. Vomited afterward and was transmitted to the ER. Other Relevant HX: Other:
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate irregular
Clinical narrative: Reported Symptoms: 10019304:HEART RATE IRREGULAR;  Narrative: Other Relevant HX: Other: IRREGULAR HEART RATE
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Cervical spinal stenosis, Electromyogram abnormal, Muscular weakness, Secretion discharge
Clinical narrative: Reported Symptoms: 10047862:WEAKNESS; Narrative: Other Relevant HX: Per PC visit 8/5/22: Upper extremity weakness of the left: EMG results showed possible Parsonage-Tuner syndrome, possibly after COVID vaccination. Patient also has cervical stenosis which we already sent him to cc neurosurgery for further evaluation. Patient is having physicial therapy to help regain strength of the upper extremity. Recommend not to excercise beyond parameters set by physical therapy to avoid further damage. Reviewed neurology recommendations that "early reinnervation seen on EMG. Would expect gradual improvement of strength, but bulk may not return as well." Discussed checking B12, and other vitamins and supplementing to maximize healing if low. Patient has a list of other supplements he is considering. Recommend that these are not evaluated by FDA for efficacy and may not work as advertised and may have unintended interactions with medications. Discussed holding off on further vaccinations given possible vaccine related reaction. A/P: Parsonage-Tuner syndrome: Continue strengthening with physical therapy. F/u PCP visit 12/7/22: Advice on immunizations: Given that there is a possibility that he got Parsonage-Tuner syndrome, possibly after COVID vaccination, would recommend at this time he avoid vaccinations. Advised him to wear mask and socially distance to avoid infection. Patient is concerned during his allergy season he has excessive mucus and feels vulnerable to flu or COVID. He is declining referral to allergist/immunologist at this juncture. Other: WEAKNESS (8/5/22@09:17:55)
Age: 64.0
Sex: M
Vaccine: PNC13
Symptoms: Peripheral swelling
Clinical narrative: Reported Symptoms: 10023698:LARGE ARM SWELLING; Narrative: Other Relevant HX:  Other: SWELLING OF ARM
Sex: M
Vaccine: FLUX
Symptoms: Anxiety, Nausea, Vomiting
Clinical narrative: Reporter Symptoms: ANXIETY; NAUSEA; VOMITING; Narrative: anxiety other relevant HX:   Other: NAUSEA AND VOMITING; ANXIETY
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Reported Symptoms: 10013963:DYSPNEA; Narrative: Other Relevant HX: Other: DYSPNEA
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Reported Symptoms: 10063978:WRONG VACCINE ADMINISTERED; Narrative: Pt due for 2nd monovalent dose of primary vaccine series, pt was given Pfizer bivalent vaccine. No adverse outcome. CDC recommendation is not to take corrective action - no additional doses of vaccine necessary. Other Relevant HX: Other: Pt due for 2nd monovalent dose of primary vaccine series, pt was given Pfizer bivalent vaccine
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Chronic obstructive pulmonary disease, Condition aggravated, Cough, Fatigue
Clinical narrative: Reported Symptoms:  10054112:HOSPITALISATION;  10084268:COVID-19;     Narrative:  67 y/o female PMH of COPD not on oxygen,  T2DM complicated by neuropathy, Barrett's esophagus status post esophagectomy, and chronic pain.  Pt presented to ED on 05/17/22 w/ complaints of fatigue, myalgias, and increased cough.  Pt admitted to hospital for COPD exacerbation secondary to COVID 19.  Bacterial PNA suspected.  Pt treated w/ dexamethasone, remdesivir (5/17-05/21) and levofloxacin.  Pt improved and discharged to home on 05/27/22.  Other Relevant HX:  67 y/o female PMH of COPD not on oxygen, T2DM complicated by neuropathy, Barrett's esophagus status post  esophagectomy, and chronic pain.  Other: COVID Infection with hospitalization
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myalgia, Pneumonia bacterial, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms:  10054112:HOSPITALISATION;  10084268:COVID-19;     Narrative:  67 y/o female PMH of COPD not on oxygen,  T2DM complicated by neuropathy, Barrett's esophagus status post esophagectomy, and chronic pain.  Pt presented to ED on 05/17/22 w/ complaints of fatigue, myalgias, and increased cough.  Pt admitted to hospital for COPD exacerbation secondary to COVID 19.  Bacterial PNA suspected.  Pt treated w/ dexamethasone, remdesivir (5/17-05/21) and levofloxacin.  Pt improved and discharged to home on 05/27/22.  Other Relevant HX:  67 y/o female PMH of COPD not on oxygen, T2DM complicated by neuropathy, Barrett's esophagus status post  esophagectomy, and chronic pain.  Other: COVID Infection with hospitalization
Age: 72.0
Sex: F
Vaccine: RSV
Symptoms: Headache, Injection site pain, Pain
Clinical narrative: 4 hrs. after vaccine - (L) arm pain (injection site) 7 hrs. after - aches all over 10 hrs. after - low grade fever - 100.2 degrees 5 days later - all above continued for 1 week with headache occuring on about day 6
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms:  10054112:HOSPITALISATION;  10084268:COVID-19;     Narrative:  86 y/o male with PMH of HTN, CAD, hyperlipidemia, paroxysmal afib, CKD3, peripheral vascular disease c/b peripheral neuropathy, hypothyroidism, and an unclear hx of diastolic HF (class II, EF 65%) and COPD.  Pt presented to ED on 5/9/22 for several days of shortness of breath, cough, congestion, after extended travel.  COVID 19 positive on 05/09/22 and admitted to hospital for minimal COVID symptoms.  Remdesivir given 05/10-5/12.  Pt improved and discharged to home on 05/12/22.  Other Relevant HX:  88 y/o male with PMH significant for CAD, afib, CKD 3, HTN, hypothyroidism, HLD, OSA, arthritis, LBP, COPD, and HF.  Other:  COVID Infection with Hospitalization
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Sudden death
Clinical narrative: Online report of sudden death in 45-year-old musician. A copy of his vax card after DOSE#1, 03/25/21 LOT#1808609, was obtained.  Any other information about subsequent inoculations is unknown.  Any previous health conditions or adverse events prior to sudden death in unknown.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema multiforme, Swelling
Clinical narrative: Reporter Symptoms: 10015218: ERYTHEMA MULTIFORM: 10042674: SWELLING; Narrative: Other Relevant HX: Swelling
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, Atrial fibrillation, Bronchial obstruction, COVID-19, Condition aggravated
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 74 y/o male with PMH significant for NSCLC dx from RUL mass biopsy on 10/2020 is s/p tx w concurrent chemo radiation w/ weekly carboplatin/paclitaxel and who was on durvalumab maintenance therepy and subsequently developed pneumonitis that was controlled on steriod therapy through June 2021, COPD on HDT, paroxysmal afib, HTN, T2DM, BPH Vit D deficiency, HLD. Pt presented to ED on 4/4/22 with SOB and found to have COVID 19 as well as interval increase in size of RUL mass invading mediastinal structures and causing complete obstruction of RU lobe bronchus. Admitted for rate control with afib with RVR started on diltiazem drip in ED. Patient was stable on 4/5, using 4L 02 at night, with no initial hypoxia noted. He was stated on CAP coverage 4/4 for concern for potential of post-obstructive pneumonia formation. Serum procalcitonin: WNL so antibiotics were discontinued. Pt initially admitted at MSDU 04/04 then downgraded to Covid unit on 04/05 and started on IV remdesivir after noted hypoxia (4/5-4/9). Acute on chronic hypoxic respiratory failure 2/2 Covid infection in the setting of recurrent NSCLC: resolved back to baseline HDT. Hypoxia improved back to baseline (HDT 2 LPM NC): 02 sat at 1 LPM NC 96% Patient was transferred to other hospital via ambulance on 4/12/22 for Palliative Radiation Therapy. Other Relevant HX: 74 y/o male with PMH significant for NSCLC dx from RUL mass biopsy on 10/2020 is s/p tx w concurrent chemo radiation w/ weekly carboplatin/paclitaxel and who was on durvalumab maintenance therapy and
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Hypoxia, Non-small cell lung cancer recurrent, Procalcitonin normal, Pulmonary mass
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 74 y/o male with PMH significant for NSCLC dx from RUL mass biopsy on 10/2020 is s/p tx w concurrent chemo radiation w/ weekly carboplatin/paclitaxel and who was on durvalumab maintenance therepy and subsequently developed pneumonitis that was controlled on steriod therapy through June 2021, COPD on HDT, paroxysmal afib, HTN, T2DM, BPH Vit D deficiency, HLD. Pt presented to ED on 4/4/22 with SOB and found to have COVID 19 as well as interval increase in size of RUL mass invading mediastinal structures and causing complete obstruction of RU lobe bronchus. Admitted for rate control with afib with RVR started on diltiazem drip in ED. Patient was stable on 4/5, using 4L 02 at night, with no initial hypoxia noted. He was stated on CAP coverage 4/4 for concern for potential of post-obstructive pneumonia formation. Serum procalcitonin: WNL so antibiotics were discontinued. Pt initially admitted at MSDU 04/04 then downgraded to Covid unit on 04/05 and started on IV remdesivir after noted hypoxia (4/5-4/9). Acute on chronic hypoxic respiratory failure 2/2 Covid infection in the setting of recurrent NSCLC: resolved back to baseline HDT. Hypoxia improved back to baseline (HDT 2 LPM NC): 02 sat at 1 LPM NC 96% Patient was transferred to other hospital via ambulance on 4/12/22 for Palliative Radiation Therapy. Other Relevant HX: 74 y/o male with PMH significant for NSCLC dx from RUL mass biopsy on 10/2020 is s/p tx w concurrent chemo radiation w/ weekly carboplatin/paclitaxel and who was on durvalumab maintenance therapy and
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Radiotherapy, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 74 y/o male with PMH significant for NSCLC dx from RUL mass biopsy on 10/2020 is s/p tx w concurrent chemo radiation w/ weekly carboplatin/paclitaxel and who was on durvalumab maintenance therepy and subsequently developed pneumonitis that was controlled on steriod therapy through June 2021, COPD on HDT, paroxysmal afib, HTN, T2DM, BPH Vit D deficiency, HLD. Pt presented to ED on 4/4/22 with SOB and found to have COVID 19 as well as interval increase in size of RUL mass invading mediastinal structures and causing complete obstruction of RU lobe bronchus. Admitted for rate control with afib with RVR started on diltiazem drip in ED. Patient was stable on 4/5, using 4L 02 at night, with no initial hypoxia noted. He was stated on CAP coverage 4/4 for concern for potential of post-obstructive pneumonia formation. Serum procalcitonin: WNL so antibiotics were discontinued. Pt initially admitted at MSDU 04/04 then downgraded to Covid unit on 04/05 and started on IV remdesivir after noted hypoxia (4/5-4/9). Acute on chronic hypoxic respiratory failure 2/2 Covid infection in the setting of recurrent NSCLC: resolved back to baseline HDT. Hypoxia improved back to baseline (HDT 2 LPM NC): 02 sat at 1 LPM NC 96% Patient was transferred to other hospital via ambulance on 4/12/22 for Palliative Radiation Therapy. Other Relevant HX: 74 y/o male with PMH significant for NSCLC dx from RUL mass biopsy on 10/2020 is s/p tx w concurrent chemo radiation w/ weekly carboplatin/paclitaxel and who was on durvalumab maintenance therapy and
Sex: M
Vaccine: COVID19
Symptoms: Myocarditis
Clinical narrative: Reported Symptoms:  10028606:MYOCARDITIS;    Narrative:  Other Relevant HX: Other: Myocarditis
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Wrong product administered
Clinical narrative: WRONG VACCINE ADMINISTERED; Pt due for 2nd monovalent  dose of primary vaccine series,  pt was given Pfizer bivalent vaccine,   Reviewed CDC recommendation - no corrective action needed.  This is now considered completion of patient's primary series. Other Relevant HX:  Pt due for 2nd monovalent  dose of primary vaccine series, pt was given Pfizer bivalent vaccine.
Sex: M
Vaccine: COVID19
Symptoms: Guillain-Barre syndrome
Clinical narrative: Reported Symptoms: 10019767:GUILLAIN-BARRE SYNDROME; Narrative: GUILLIAN BARRE SYNDROME Other Relevant HX: Other: GUILLIAN BARRE SYNDROME
Age: 31.0
Sex: M
Vaccine: PPV
Symptoms: Injection site pain
Clinical narrative: Reported Symptoms: 10022086:INJECTION SITE PAIN; Narrative: Other Relevant HX: Other: INJECTION SITE PAIN
Sex: F
Vaccine: FLUX
Symptoms: Erythema, Erythema multiforme, Injection site erythema, Injection site swelling, Swelling
Clinical narrative: Reported Symptoms: 10015150:ERYTHEMA; 10015218:ERYTHEMA MULTIFORME; 10042674:SWELLING; Narrative: Other Relevant HX: Dec 04, 2021 - patient reported swelling and erythema to injection site 3x4 cm localized area per EOH. Patient received flu shot outside facility - no vaccine record/documentation available. Other: SWELLING; ERYTHEMA
Sex: M
Vaccine: FLUX
Symptoms: Guillain-Barre syndrome
Clinical narrative: Reported Symptoms: 10018767:GUILLAIN-BARRE SYNDROME; Narrative: Historical reaction, no record of vaccination details/reaction in chart available. Other Relevant HX: Other: GUILLAIN BARRE (5/3/22@10:06:15)
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Pruritus, Urticaria
Clinical narrative: Reported Symptoms:  10037087:PRURITUS;  10046735:URTICARIA;    Narrative:  Other Relevant HX: Per PC visit 6/6/2022:  Patient also mentioned that he recently had a Covid booster questionably a few months ago and he broke out in hives. --> no vaccination records in chart for this booster dose; unsure which COVID vaccine was administered. Patient did receive COVID-19 Moderna vaccinations documented, from outside facility 2/1/21 and 3/1/21. Of note, patient also has - CHRONIC URTICARIA WITH SOB HX(takes Zyrtec prn and also uses inhalers, also has Epipen).    Other: URTICARIA (6/6/22@11:58:31)
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Reported Symptoms: SWELLING; Pt treated himself at home w/ Benadryl.   Pt also has known shellfish allergy.  Other Relevant HX-  Other-  SWELLING
Age: 61.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cough, Dysphonia, Epistaxis
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10015090:EPISTAXIS; 10020201:HOARSENESS; Narrative: Other Relevant HX: Pt received 2nd COVID Moderna booster 6/24/22 and reports SE started shortly after as per patient and MD documentation on 8/9/22 visit note. Other: HOARSENESS (8/15/22@10:38:30); COUGH (8/15/22@10:38:30); EPISTAXIS (8/15/22@10:38:30)
Age: 69.0
Sex: M
Vaccine: VARZOS
Symptoms: Urticaria
Clinical narrative: Reported Symptoms: 10046735:URTICARIA; Narrative: Other Relevant HX: Other: URTICARIA
Sex: M
Vaccine: FLUX
Symptoms: Adverse drug reaction
Clinical narrative: Reported Symptoms: 10061623:ADVERSE DRUG REACTION; Narrative: unknown event, unknown treatment Other Relevant HX: Other: unknown
Sex: M
Vaccine: FLUA4
Symptoms: Peripheral swelling
Clinical narrative: Reported Symptoms: 10023698:LARGE ARM SWELLING; Narrative: History of arm swelling, did not happen with repeat influenza vaccine. Other Relevant HX: Other: arm swelling
Sex: M
Vaccine: FLUX
Symptoms: Increased viscosity of upper respiratory secretion, Sputum retention
Clinical narrative: Reported symptoms: 10076752:OROPHARYNGEAL MUCUS THICKENING;    Narrative: Other Relevant hx:     Other:  THICK MUCOUS HE CANNOT COUGH UP
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Computerised tomogram head normal, Disorientation, Laboratory test normal
Clinical narrative: Reported Symptoms: 10047662:WEAKNESS; 10047865:WEAKNESS GENERALIZED;  Narrative: 77 y/o with history afib, hypertension, CHF, CAD, h/o CVA, diabetes presented to ER with increased generalized weakness 10/21/22.  He received Moderna bivalent booster on 10/20/22, the next morning he was more disoriented and required increased help to transfer.  W/U unremarkable for infection, CT negative for intracranial hemorrhages, stroke and seizures ruled out. Patient improved without change in medication. Was discharged 10/25/22. No prior ADRs reported to past COVID19 vaccines. Other Relevant HX:  Other: weakness
Sex: M
Vaccine: FLUX
Symptoms: Guillain-Barre syndrome, Miller Fisher syndrome
Clinical narrative: Reported Symptoms: 10018767:GUILLAIN-BARRE SYNDROME; 10049567:MILLER FISHER SYNDROME; Narrative: Other Relevant HX: 01/25/22 Primary Care New Patient Intake patient reported reaction to influenza vaccine resulting in Miller Fisher Variant of Gullian Barre Syndrome in 2008 (exact date unknown). No records of influenza vaccines administered since that time. Other: GUILLAIN BARRE, Miller Fisher variant
Sex: M
Vaccine: COVID19
Symptoms: Hyperglycaemia
Clinical narrative: Reported Symptoms: 10020639:HYPERGLYCEMIA; Narrative: Other Relevant HX: Received vaccination outside of reporting hospital; vaccination details unavailable. Unclear when hyperglycemia occurred. Doses were received as follows: COVID-19 (MODERNA), MRNA, LNP-5, 3 11/04/2022 2 01/27/2021 1 12/30/2020 Other: HYPERGLYCEMIA (8/22/22@14:53:57)
Age: 74.0
Sex: M
Vaccine: FLUX
Symptoms: Chills, Pyrexia, Tremor
Clinical narrative: Reported Symptoms: 10008531: CHILLS; 10016558:FEVER;  10044565:TREMOR; Narrative:  Other Relevant HX:  Other: FEVER; CHILL; TREMOR
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, COVID-19, Fall, Syncope
Clinical narrative: Reported Symptoms: 10013573:DIZZINESS; 10016178:FALLING DOWN; 10042772:SYNCOPE; 10047862:WEAKNESS; 10084268:COVID-19; Narrative: Patient received three doses of Pfizer COVID 19 vaccine in Jan/Oct 21. The patient presented to the ED on 31 Dec 22 with severe weakness that caused the patient to fall. The patient was admitted for COVID 19 for observation. The patient was discharged in stable condition on 3 Jan 2023. Reported per EUA. Other Relevant HX: Other: Covid 19, severe weakness and fall
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Gait inability, Hyperglycaemia, Hypertension, Nasal congestion
Clinical narrative: Reported Symptoms: 10020639:HYPERGLYCEMIA; 10020772:HYPERTENSION; 10028735:NASAL CONGESTION; 10047862:WEAKNESS; Narrative: Other Relevant HX: Patient was admitted at Medical Center and Rehab. After discharge he reported that the COVID booster caused him adverse reactions on 2/14/22. 1. Cannot walk/weakness, 2. Uncontrolled hyperglycemia, 3. Uncontrolled hypertension, 4. Congestion. Likely received COVID booster at outside facility; no vaccine records/documentation available for 2022. Patient received COVID vaccine series from facility in 2021 (11/19/2021, 2/16/2021, 1/19/2021) without adverse effects charted. Unsure which vaccine booster he received 2/2022. Other: HYPERGLYCEMIA; HYPERTENSION; NASAL CONGESTION; WEAKNESS
Age: 80.0
Sex: M
Vaccine: FLUA4
Symptoms: Chills, Dyspnoea, Dysuria
Clinical narrative: Reported Symtoms: 10008531:CHILLS; 10013963:DYSPNEA; Narrative: Other Relevant HX: Other: DYSURIA, Chills
Sex: M
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: Reported Symptoms: 10008479:CHEST PAIN; Narrative: Other Relevant HX: Other: CHEST PAIN
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Dizziness, Dyspnoea, Hemiparesis, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms:  10013573:DIZZINESS;  10043088:TACHYPNEA;  10084268:COVID-19;     Narrative:  Patient received one dose Janssen COVID 19 Vaccine (May 2021) and one dose Pfizer COVID 19 Vaccine (Apr 2022).  The patient presented to the ED on 8 Dec 2022 with left sided weakness and shortness of breath.  The patient tested positive for COVID 19 on 8 Dec 2022 and was admitted to the hospital with COVID 19 for observation.  The patient was discharged on 12 Dec 22 in stable condition.  Resported per EUA.  Other Relevant HX:  Other: COVID 19
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tachypnoea
Clinical narrative: Reported Symptoms:  10013573:DIZZINESS;  10043088:TACHYPNEA;  10084268:COVID-19;     Narrative:  Patient received one dose Janssen COVID 19 Vaccine (May 2021) and one dose Pfizer COVID 19 Vaccine (Apr 2022).  The patient presented to the ED on 8 Dec 2022 with left sided weakness and shortness of breath.  The patient tested positive for COVID 19 on 8 Dec 2022 and was admitted to the hospital with COVID 19 for observation.  The patient was discharged on 12 Dec 22 in stable condition.  Resported per EUA.  Other Relevant HX:  Other: COVID 19
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash, Urticaria
Clinical narrative: Reported Symptoms:  10037087:PRURITUS; 10037844:RASH;  10046735:URTICARIA; Narrative:  Other Relevant HX:  Other: URTICARIA; GENERALIZED RASH
Sex: M
Vaccine: FLUX(H1N1)
Symptoms: Nausea, Vomiting
Clinical narrative: Reported Symptoms: 10028813:NAUSEA; 10047700:VOMITING; Narrative: Other Relevant HX: Other: NAUSEA AND VOMITING
Sex: M
Vaccine: COVID19
Symptoms: Asthenia
Clinical narrative: Reported Symptoms: 10047862:WEAKNESS; 10047865:WEAKNESS GENERALIZED; Narrative: Patient repoted increased weakness in hands and legs after 2nd COVID vaccine. Weakness in hands reported as resolved but legs remains. Patient also has history of myasthenia gravis. Other Relevant HX: Other: WEAKNESS
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Reported Symptoms:   10037844:RASH;    Narrative:  Other Relevant HX:  Other:
Sex: M
Vaccine: FLU4
Symptoms: Anaphylactic reaction, Hypersensitivity, Pruritus, Urticaria
Clinical narrative: Reported Symptoms: 10002218:ANAPHYLAXIS; 10037087:PRURITUS; 10046735:URTICARIA; Narrative: Patient has not received influenza vaccine since event. Appears patient did tolerate previous different formulation of influenza vaccine. No noted complications from vaccine noted in patient chart since event was reported in 01/28/22. Other Relevant HX: In 01/28/22 Preventative Health Note, patient reported severe allergic reaction (e.g. anaphylaxis) to a vaccine component in fall 2016. No patient records indicate that pt received vaccine or was treated for reaction at facilities. No notes from that time available for further details of reaction or treatment. However, records indicate patient did received quadrivalent influenza vaccine with preservative 10/05/17. Patient had previously received Seqirus preservative free vaccine in 10/2016 and did not report complications from that injection. Other: PRURITUS; URTICARIA
Age: 77.0
Sex: M
Vaccine: FLUA4
Symptoms: Fatigue
Clinical narrative: Reported Symptoms: SEDATION; 77 YO male w/ H/o Afib, CHF , HTN, and PTSD. Patient was administered the influenza vaccination Fluad on 11/15. Patient noted to PCP that vaccination caused tiredness, PCP was unable to determine etiology. No h/x of reaction to any vaccination in the past. Patient is taking the following medications amiodarone, cholecalciferol, furosemide, losartan, potassium chloride, apixaban, and metoprolol. Other Relevant HX: 77 male patient w/ h/o HTN, PTSD, obesity, Afib, CAD, BPH, ED, and NFrEF. Patient reported that two days after his visit to his pcp he started having tiredness after walking.  Patient was given an influenza vaccine at that visit. Patient noted he had a very bad reaction to the flu shot 46 years ago, though is unable to recall the previous reaction other than being very bad. Patient was on the following medications - amiodarone,  cholecalciferol,  furosemide,  metoprolol tartrate,  and potassium choklirde.  ADR was documented in the patients chart to the influenza vaccine. Other: FATIGUE
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Angioedema, Nausea, Oedema, Vomiting
Clinical narrative: Reported Symptoms: 10002424:ANGIOEDEMA; 10014210:EDEMA; 10028813:NAUSEA; 10047700:VOMITING; Narrative: Other Relevant HX: Other: NAUSEA; EDEMA
Sex: F
Vaccine: FLUX
Symptoms: Rash
Clinical narrative: Reported Symptoms: 10037844:RASH; Narrative: Other Relevant HX: Other:
Age: 80.0
Sex: M
Vaccine: FLUA4
Symptoms: Chills, Dyspnoea
Clinical narrative: Reported Symptoms: 10008531:CHILLS; 10013963:DYSPNEA; Narrative: Other Relevant HX: Other: DYSPNEA, Chills
Age: 70.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Hyperglycaemia, Therapy change
Clinical narrative: Reported Symptoms:  10020639:HYPERGLYCEMIA;     Narrative: Pt is 70yom with PMH T2DM, pt came in to clinic on 10/25/22 for routine influenza vaccine. Pt received the intramuscular Influenza Quadrivalent, Adjuvanted (FLUAD) vaccine in his left deltoid. Pt experienced no immediate ade to receiving the vaccine. On 11/22/22 he pt reported that after receiving the flu vaccine and going home his blood sugar readings were hyperglycemic and in the 180s. Prior to reporting this ade on 11/22/22 the pt also received the moderna bivalent booster on 1/01/22. Pt reported that he was increasing the amount of units of insulin he was taking in order to lower his blood glucose readings. On 12/5/22 pt had f/u and reported that his blood sugar readings were starting to come down. On 1/9/23 pt had f/u and stated that his blood sugar readings were still high but no longer hyperglycemic and pt was restarted on empagliflozin. On 3/8/23 pt reported his blood sugar readings were back to normal with no issues. Other Relevant HX:  Other: HYPERGLYCEMIA (11/22/22@06:43:57)
Sex: M
Vaccine: FLUX
Symptoms: Anaphylactic reaction
Clinical narrative: Reported Symptoms: 10002218:ANAPHYLAXIS; Narrative: Historical reaction documented upon establishing care with PCP. Unclear if true anaphylaxis. No details of vaccine records - unclear when it was received and what occurred. Other Relevant HX: Per PC intake visit 2/1/22: Influenza Immunization: Deferred due to a precaution: Other precaution: Comment: allergy **No records or details available on chart. Unclear when patient received flu shot or extent of reaction. Other: ANAPHYLAXIS
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Reported Symptoms: 10037844: Rash; Narrative: Other Relevant HX: OTher Rash.
Sex: M
Vaccine: FLUX
Symptoms: Adverse drug reaction
Clinical narrative: Reported Symptoms: 10061623:ADVERSE DRUG REACTION; Narrative: Other Relevant HX: Other: Unknown Historical report
Sex: M
Vaccine: COVID19
Symptoms: Hyperglycaemia
Clinical narrative: Reporter Symptoms: 10020639:Hyperglycemia: Narrative: Other Relevant HX: Patient received COVID-19 vaccination outside center, no vaccine record details/documentation available. COVID-19 (PFIZER), MRNA, 11/2/2021, 03/30/2021, 03/09/2021 Other Hyperglycemia
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Pyrexia
Clinical narrative: Reported Systems: 10054112: Hospitalization: 10884401: COVID-19 Respiratory Infection; Narrative: Patient presented to ED on 02/24/24 and diagnosed with COVID19; he was given antivirals and then sent home. However, the next day he came back for fever not controlled with Tylenol and increased weakness. He was given fluids and started on remdesivir. Other Relevant HX: Other: Hospitalization for COVID19.
Sex: M
Vaccine: FLUX
Symptoms: Dizziness, Malaise
Clinical narrative: Reported Symptoms:  10013573:DIZZINESS;  10016365:FEELING SICK; Narrative:   Other Relevant hx:   Other:  "very sick after receiving in the past" per CCF. ROT recieved 11/21
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Anaphylactic reaction
Clinical narrative: Reported Symptoms: 10002218:ANAPHYLAXIS; Narrative: Other Relevant
Age: 57.0
Sex: M
Vaccine: PNC13, TDAP
Symptoms: Hypersensitivity, Pruritus, Urticaria
Clinical narrative: Reported Symptoms: 10037087:PRURITUS; 10046735:URTICARIA; Narrative: 12/22/21 note: Patient contacted this writer to report an allergic reaction to the vaccines (Prevnar 13 and Tdap) that he received in clinic yesterday. He work up with hives all over his body. Denies feeling like his tongue, throat, lips feel swollen. Denies SOB or difficulty breathing. Reports he has taken a Benadryl about 5-10 minutes before calling. Advised the patient (erring on the side of caution) to come to the UCC or go to his local UCC/ER and call us when he gets home. Patient declines at this time preferring to wait to see how the Benadryl works. Agrees to seek treatment as mentioned above if he starts to have any breathing difficulties or feels like his chest is tight, or lips, tongue or throat are swelling. Patient will call after treatment Other Relevant HX: Other: URTICARIA
Age: 57.0
Sex: M
Vaccine: TDAP
Symptoms: Allergy to vaccine, Hypersensitivity, Pruritus, Urticaria
Clinical narrative: Reported Symptoms: 10037087:PRURITUS; 10046735:URTICARIA; Narrative: 12/22/21 note: Patient contacted this writer to report an allergic reaction to the vaccines (Prevnar 13 and Tdap) that he received in clinic yesterday. He work up with hives all over his body. Denies feeling like his tongue, throat, lips feel swollen. Denies SOB or difficulty breathing. Reports he has taken Benadryl about 5-10 minutes before calling. Advised the Patient (erring on the side of caution) to come to this UCC or go to his local UCC/ER and call us when he gets home. Patient declines at this time preferring to wait to see how the Benadryl works. Agrees to seek treatment as mentioned above if he starts to have any breathing difficulties or feels like his chest is tight, or lips, tongue or throat are swelling. Patient will call after treatment Other Relevant HX: Other: URTICARIA
Sex: M
Vaccine: COVID19
Symptoms: Thrombosis
Clinical narrative: Reported Symptoms: 10043607:THROMBOSIS; Narrative: Other Relevant HX: Other: THROMBOSIS
Sex: F
Vaccine: COVID19
Symptoms: Lacrimation increased, Nasal congestion
Clinical narrative: Reported Symptoms:  10028735:NASAL CONGESTION; 10047648:WATERING EYES; Narrative:  Other Relevant HX:  Other: NASAL CONGESTION; WATERING EYE
Age: 69.0
Sex: M
Vaccine: PPV
Symptoms: Rash
Clinical narrative: Reported Symptoms:   10037844:RASH;    Narrative:   Other Relevant HX:  Other:
Sex: M
Vaccine: FLUX
Symptoms: Chills, Diarrhoea, Myalgia, Pyrexia
Clinical narrative: Reported Symptoms:  10008531:CHILLS;  10012727:DIARRHEA;  10016559:FEVER; 10028322:MUSCLE PAIN;     Narrative:   Other Relevant HX:   Other:  DIARRHEA:  FEVER:  CHILL:  MUSCLE PAIN
Sex: F
Vaccine: FLUX
Symptoms: Adverse drug reaction
Clinical narrative: Reported Symptoms:  10061623:ADVERSE DRUG REACTION.     Narrative: Pharmacist reported that per remote data, pt has an ADR to influenza vaccine. Exact reaction was not disclosed. Other Relevant HX:   Other: not disclosed from remote data
Sex: M
Vaccine: FLUX
Symptoms: Vertigo
Clinical narrative: Reported Symptoms:  10047340:VERTIGO;    Narrative:   Other Relevant HX:
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Throat irritation
Clinical narrative: Reported Symptoms: 10053560: Itchy Throat: Narrative: Other Relevant HX: Itchy Throat.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Palpitations, Vertigo
Clinical narrative: Reported Symptoms: 10013573:DIZZINESS; 10019211:HEADACHE; 10033556:PALPITATION; 10047340:VERTIGO; Narrative: Resolved after 5 months. Other Relevant HX: Other: HEADACHE; VERTIGO; PALPITATIONS
Sex: M
Vaccine: FLUX
Symptoms: Cough, Nasal congestion, Pain, Pyrexia, Rhinorrhoea
Clinical narrative: Reported Symptoms:  10000474:ACHE'  10011232:COUGHING:  10013773:DRY COUGH;  10016558:FEVER;  10028735:NASAL CONGESTION;  10028737:NASAL DISCHARGE;  100041232:SNEEZING;     Narrative:  Other Relevant HX: Received flu shot from Pharmacy 9/4/21. Patient reported that he was tested for COVID 9/3/21 but was asymptomatic, had flu vaccine at pharmacy 9/4/21, on 9/6/21 began having achiness, dry cough, sneezing, low grade fever, states he sometimes has these symptoms after flu vaccine in the past.  An discussed with patient getting COVID tested again at same place and updating clinic. Also advised quarantine, fluids rest. Follow-up:  no COVID-19 postitive test reported. Other: NASAL DISHCARGE, congestion, achiness, dry cough, sneezing, low grade fever
Sex: M
Vaccine: FLUX
Symptoms: Sneezing
Clinical narrative: Reported Symptoms:  10000474:ACHE'  10011232:COUGHING:  10013773:DRY COUGH;  10016558:FEVER;  10028735:NASAL CONGESTION;  10028737:NASAL DISCHARGE;  100041232:SNEEZING;     Narrative:  Other Relevant HX: Received flu shot from Pharmacy 9/4/21. Patient reported that he was tested for COVID 9/3/21 but was asymptomatic, had flu vaccine at pharmacy 9/4/21, on 9/6/21 began having achiness, dry cough, sneezing, low grade fever, states he sometimes has these symptoms after flu vaccine in the past.  An discussed with patient getting COVID tested again at same place and updating clinic. Also advised quarantine, fluids rest. Follow-up:  no COVID-19 postitive test reported. Other: NASAL DISHCARGE, congestion, achiness, dry cough, sneezing, low grade fever
Sex: M
Vaccine: FLUX
Symptoms: Unevaluable event
Clinical narrative: Reported Symptoms: Narrative: Other Relevant HX: Other: unknown
Age: 68.0
Sex: M
Vaccine: FLUX
Symptoms: Hypotension
Clinical narrative: Reported Symptoms: 10021097:HYPOTENSION; Narrative: Other Relevant HX: 09/15/2021 patient reported to primary care provider that he experienced hypotension requiring a visit to the ER following an influenza vaccine in ~ 2007 (exact date unknown). No records to indicate this vaccine was given at this facility. No influenza immunization from that time documented in EMR. Other: HYPOTENSION
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Burning sensation, Dizziness, Hallucination, auditory
Clinical narrative: Reported Symptoms: 10003239:ARTHRALGIA; 10013573:DIZZINESS; 10019077:HALLUCINATIONS; Narrative: Patient received a dose of the J&J/Janssen vaccine on 3/5/21. She received a Moderna booster dose on 11/5/21. She reports onset of auditory hallucinations later on 11/5/21, hearing voices and animals (dogs barking). Also reports "body was on fire" (no temperature taken), dizziness and joint pain. Symptoms lasted ~ 3 days. Other Relevant HX: Other:
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Muscular weakness, Road traffic accident, Syncope
Clinical narrative: Reported Symptoms: 10042772:SYNCOPE; 10047862:WEAKNESS; Narrative: Patient received his 2nd Moderna vaccine dose on 3/13/21. On 3/15/21 he suffered a motor vehicle accident, and just prior to that accident he reported weakness in arms and legs and possible momentary loss of consciousness. He was admitted following the accident overnight and no cause of symptoms identified. No additional episodes of syncope reported. No atrial fibrillation and neurology evaluated and ruled out a seizure disorder. At f/u visit in October 2021 patient reported to his primary care provider that he felt symptoms were due to the vaccine. Other Relevant HX: Other: syncope, weakness
Age: 56.0
Sex: M
Vaccine: FLU4
Symptoms: Blood glucose increased, Diabetes mellitus management, Hyperglycaemia
Clinical narrative: Reported Symptoms: 10020639:HYPERGLYCEMIA;  Narrative:  57yoM with PMH of obesity, DM w/neuropathy, GERD, Fatty Liver, HLD, HTN and Hypothyroidism called in to clinic on 11/21/22 to report elevated blood sugar readings after receiving influenza vaccine on 11/9/22. Pt then f/u w/ pharmacist for initial DM management on 11/13/22. No interventions were taken for the elevated BG readings after influenza vaccination. Other Relevant HX: Other: HYPERGLYCEMIA (11/23/22@14:45:42)
Sex: M
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: Reported Symptoms: 10008479:CHEST PAIN;  Narrative:  Other Relevant HX: Other: CHEST PAIN
Sex: M
Vaccine: FLUX
Symptoms: Injection site pain, Myalgia
Clinical narrative: Reported Symptoms:  10020322:MUSCLE PAIN;  10028411:MYALGIA;    Narrative: Other Relevant HX: On 11/9/21,  patient reported to Employee Health that he had pain on his left deltoid at the injection site since he received the flu vaccine on 9/28/21.  No vaccination record documentation available; patient have received the flu shot outside of the clinic.  Other: MUSCLE PAIN
Sex: M
Vaccine: FLUX
Symptoms: Electromyogram normal, Guillain-Barre syndrome
Clinical narrative: Reported Symptoms: 10018767:GUILLAIN-BARRE SYNDROME; Narrative: Has followed by neurology records pending. Pt denies hx. He stated his EMG did not show GBS. Dx removed from problem list. Other Relevant HX: Other: GUILLAIN BARRE
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperglycaemia
Clinical narrative: Reported Symptoms: 10020639:HYPERGLYCEMIA; Narrative: Patient has received the following COVID vaccinations. Unclear when hyperglycemia occurred. ADR documented 11/23/2022. Patient also documented to have hyperglycemia from flu vaccine, with flu vaccine admin dates listed below as well. COVID-19 (JANSSEN), 12/08/2021, 03/18/2021 COVID-19 (MODERNA), MRNA, LNP-5: 03/07/2023 COVID-19 (MODERNA), MRNA, LNP-5: 05/02/2022 INFLUENZA, INJECTABLE, QUAD: 11/09/2022, 11/01/2021, 09/16/2019 Other Relevant HX: Patient has received the following COVID vaccinations. Unclear when hyperglycemia occurred. ADR documented 11/23/2022. Patient also documented to have hyperglycemia from flu vaccine, with flu vaccine admin dates listed below as well. COVID-19 (JANSSEN), 12/08/2021, 03/18/2021 COVID-19 (MODERNA), MRNA, LNP-5: 03/07/2023 COVID-19 (MODERNA), MRNA, LNP-5: 05/02/2022 INFLUENZA, INJECTABLE, QUAD: 11/09/2022, 11/01/2021, 09/16/2019 Other: HYPERGLYCYEMIA (11/23/22@15:00:11)
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: Lethargy, Myalgia, Pyrexia
Clinical narrative: Reported Symptoms:  10016553:FEVER; 10024264:LETHARGY; 10029411:MYALGIA; Narrative: Other Relevant HX: Other: Lethargy
Sex: F
Vaccine: FLUX
Symptoms: Arthralgia, Myalgia, Tendonitis
Clinical narrative: Reported Symptoms:  10028411:MYALGIA; 10043255:TENDONITIS;      Narrative: Other Relevant HX:  Patient seems to have received influenza vaccine in 2021 (no VA records/documentation available for this shot) and reported L shoulder pain, possible tendonitis after the vaccine.  Patient has since received  the flu shot in 2022.    Other: TENDONITIS (12/31/21@19:45)
Sex: M
Vaccine: COVID19-2
Symptoms: Chest pain, Dyspnoea exertional, Palpitations
Clinical narrative: Reported Symptoms:  10008479:CHEST PAIN; 10033556:PALPITATION; Narrative:  Other Relevant HX: Received moderna covid booster on 11/22/21, Within a few days began to experience chest pain, palpitations, dyspnea on exertion. Referred to w.c. and pad for evaluation to ask for cards consult. Patient received the booster outside the facility, no vaccination records available. Other: PALPITATIONS; CHEST PAIN
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Extra dose administered
Clinical narrative: Reported Symptoms: 10064366: EXTRA DOSE ADMINISTERED;  Narrative:  Other Relevant HX:  Other: Patient Received 2nd bivalent vaccine
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Antimicrobial susceptibility test resistant, Asthenia, Breakthrough COVID-19, COVID-19 pneumonia
Clinical narrative: Reported Symptoms: 10011906:DEATH; 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084268:COVID-19; Narrative:  80-year-old male with a PMH of HTN, HLD, CAD, T2DM , memory impairment, presenting to the ED for weakness and hypotension after PICC line  removal in ID clinic.  Patient admitted on 10/5 for Acute hypoxic respiratory  failure 2/2 to severe COVID pneumonia requiring supplemental oxygenation.  Continued on 5 doses of Remdesavir (10/6-10/10) and 10-day course of  dexamethasone (10/7-10/16) for COVID pneumonia.  Patient transferred to MICU for  higher oxygen supplementation with possibility of progression to CPAP or  intubation. Discussed with patient of risks/benefits of escalation to intubation; patient understood with confirmation of CODE status FULL  and MPOA as  roommate if unable to communicate cares. Additional MPOA identified on AD from 2015.  Sputum speciated ESBL Klebsiella, treated  with ertapenem per ID.  C diff positive,  treated with PO vanc through Duotube.  Hospitalization complicated by UGIB,  endoscopy by GI on 10/12 with multiple  duodenal ulcers s/p cliping. S/p 2u RBC. No recurrence of bleeding, even after  Duotube replacement. Continued mechanical ventilation increasing Fi02  requirements for prolonged duration. Encephalopathy and hypoactive delirium with  inability to follow commands while off sedation. Atempted high dose steroid  ARDS NET protocol on 10/18 with improvement in Fi02 levels.  10/18 sputum CX  concerning for possible carbapenemase resistance however discussed with ID and  since
Sex: M
Vaccine: COVID19-2
Symptoms: Central venous catheterisation, Chest X-ray abnormal, Clostridium difficile infection, Clostridium test positive, Death
Clinical narrative: Reported Symptoms: 10011906:DEATH; 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084268:COVID-19; Narrative:  80-year-old male with a PMH of HTN, HLD, CAD, T2DM , memory impairment, presenting to the ED for weakness and hypotension after PICC line  removal in ID clinic.  Patient admitted on 10/5 for Acute hypoxic respiratory  failure 2/2 to severe COVID pneumonia requiring supplemental oxygenation.  Continued on 5 doses of Remdesavir (10/6-10/10) and 10-day course of  dexamethasone (10/7-10/16) for COVID pneumonia.  Patient transferred to MICU for  higher oxygen supplementation with possibility of progression to CPAP or  intubation. Discussed with patient of risks/benefits of escalation to intubation; patient understood with confirmation of CODE status FULL  and MPOA as  roommate if unable to communicate cares. Additional MPOA identified on AD from 2015.  Sputum speciated ESBL Klebsiella, treated  with ertapenem per ID.  C diff positive,  treated with PO vanc through Duotube.  Hospitalization complicated by UGIB,  endoscopy by GI on 10/12 with multiple  duodenal ulcers s/p cliping. S/p 2u RBC. No recurrence of bleeding, even after  Duotube replacement. Continued mechanical ventilation increasing Fi02  requirements for prolonged duration. Encephalopathy and hypoactive delirium with  inability to follow commands while off sedation. Atempted high dose steroid  ARDS NET protocol on 10/18 with improvement in Fi02 levels.  10/18 sputum CX  concerning for possible carbapenemase resistance however discussed with ID and  since
Sex: M
Vaccine: COVID19-2
Symptoms: Delirium, Duodenal ulcer, Encephalopathy, Endoscopy abnormal, Fraction of inspired oxygen
Clinical narrative: Reported Symptoms: 10011906:DEATH; 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084268:COVID-19; Narrative:  80-year-old male with a PMH of HTN, HLD, CAD, T2DM , memory impairment, presenting to the ED for weakness and hypotension after PICC line  removal in ID clinic.  Patient admitted on 10/5 for Acute hypoxic respiratory  failure 2/2 to severe COVID pneumonia requiring supplemental oxygenation.  Continued on 5 doses of Remdesavir (10/6-10/10) and 10-day course of  dexamethasone (10/7-10/16) for COVID pneumonia.  Patient transferred to MICU for  higher oxygen supplementation with possibility of progression to CPAP or  intubation. Discussed with patient of risks/benefits of escalation to intubation; patient understood with confirmation of CODE status FULL  and MPOA as  roommate if unable to communicate cares. Additional MPOA identified on AD from 2015.  Sputum speciated ESBL Klebsiella, treated  with ertapenem per ID.  C diff positive,  treated with PO vanc through Duotube.  Hospitalization complicated by UGIB,  endoscopy by GI on 10/12 with multiple  duodenal ulcers s/p cliping. S/p 2u RBC. No recurrence of bleeding, even after  Duotube replacement. Continued mechanical ventilation increasing Fi02  requirements for prolonged duration. Encephalopathy and hypoactive delirium with  inability to follow commands while off sedation. Atempted high dose steroid  ARDS NET protocol on 10/18 with improvement in Fi02 levels.  10/18 sputum CX  concerning for possible carbapenemase resistance however discussed with ID and  since
Sex: M
Vaccine: COVID19-2
Symptoms: Hypotension, Intensive care, Klebsiella infection, Mechanical ventilation, Red blood cell transfusion
Clinical narrative: Reported Symptoms: 10011906:DEATH; 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084268:COVID-19; Narrative:  80-year-old male with a PMH of HTN, HLD, CAD, T2DM , memory impairment, presenting to the ED for weakness and hypotension after PICC line  removal in ID clinic.  Patient admitted on 10/5 for Acute hypoxic respiratory  failure 2/2 to severe COVID pneumonia requiring supplemental oxygenation.  Continued on 5 doses of Remdesavir (10/6-10/10) and 10-day course of  dexamethasone (10/7-10/16) for COVID pneumonia.  Patient transferred to MICU for  higher oxygen supplementation with possibility of progression to CPAP or  intubation. Discussed with patient of risks/benefits of escalation to intubation; patient understood with confirmation of CODE status FULL  and MPOA as  roommate if unable to communicate cares. Additional MPOA identified on AD from 2015.  Sputum speciated ESBL Klebsiella, treated  with ertapenem per ID.  C diff positive,  treated with PO vanc through Duotube.  Hospitalization complicated by UGIB,  endoscopy by GI on 10/12 with multiple  duodenal ulcers s/p cliping. S/p 2u RBC. No recurrence of bleeding, even after  Duotube replacement. Continued mechanical ventilation increasing Fi02  requirements for prolonged duration. Encephalopathy and hypoactive delirium with  inability to follow commands while off sedation. Atempted high dose steroid  ARDS NET protocol on 10/18 with improvement in Fi02 levels.  10/18 sputum CX  concerning for possible carbapenemase resistance however discussed with ID and  since